Medico-social evaluation of the long-term pharmacotherapy of schizophrenia. Comparative study of fluphenazine and pimozide.
1. A controlled clinical trial has shown oral pimozide to be clinically at least as effective as fluphenazine decanoate in the continuation treatment of schizophrenia. 2. Pimozide was also associated with more favourable measures of social outcome. 3. Some implications of these findings are discussed.
D000293:Adolescent; D000328:Adult; D002986:Clinical Trials as Topic; D003863:Depression; D005476:Fluphenazine / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D010868:Pimozide / Q000009:adverse effects / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy*; D012919:Social Behavior
D010868:Pimozide; D005476:Fluphenazine